Subscribe   RSS Contact Us

OPDP Issues Just Two Enforcement Letters in First Half of 2016

July 22, 2016 – Although 2015 was considered a slow year for enforcement letters issued by the FDA’s Office of ... read more

Gender and Healthcare Communications

By Nick Colucci, Publicis Health CEO July 21, 2016 — I was moved by a recent op-ed in The New ... read more

Medical Associations Support Bill Exempting Journals and Textbooks from Sunshine Reporting

July 15, 2016 – More than 100 medical associations, including the American Medical Association, signed a letter of support for ... read more

Pfizer Gets in Front of Opioid Marketing Issue

July 8, 2016 – As organized medicine, politicians and the public seek to reverse the scourge of opioid addiction, Pfizer ... read more

Bill Gates Defends U.S. Drug Pricing System

July 1, 2016 – Amidst criticism over the high cost of drugs in this country, billionaire and philanthropist Bill Gates ... read more

CEOs to Coalition’s Rising Leaders: Engage in Political Process, Keep Learning

June 17, 2016 – In order to stay ahead of change, further their careers and forward the positive message of ... read more

Washington Health Policy Focus Is on Drug Innovation, Reform and Pricing, Rawson Says

June 13, 2016 – Before and after the 2016 elections, Washington health policy will remain fixed on improving the path ... read more

Davidson Sums Up Past and Current State of DTC Ad Restrictions, Ad Tax Deduction

June 7, 2016 – The Advertising Coalition (TAC) Executive Director Jim Davidson gave industry’s next generation a comprehensive overview of ... read more

Courts’ Support for “Truthful and Non-misleading” Speech Has Not Yet Resulted in FDA Policy Change

May 31, 2016 – Although the U.S. Supreme Court and other courts consistently are deciding cases in favor of First ... read more

Congressman Jenkins to Coalition’s Rising Leaders: You Have the Power to Influence Lawmakers

May 24, 2016 – At a recent Coalition for Healthcare Communication Rising Leaders Conference, keynote speaker Rep. Evan Jenkins (R-W. ... read more

The Advertising Coalition Reminds FDA of First Amendment Limits to Advertising Regulation

May 9, 2016 – In an April 29 comment to the FDA on its recent proposal to conduct research on ... read more

Drug Companies Should Be Able to Share Information with Payers

May 2, 2016 – In order to make reasonable coverage decisions about new medicines, payers need access to information from ... read more

Commissioner of Food and Drugs Califf Lists Advertising, Labeling Among Priorities

April 25, 2016 — In a speech at the Alliance for a Stronger FDA’s quarterly meeting April 19, new Commissioner ... read more

NYTimes: Ban on Drug Ads Would Also Eliminate Ad Benefits

March 14, 2016 — The American Medical Association (AMA) as well as Rep. Rosa DeLauro (D-Conn.) and Sen. Al Franken ... read more

Sen. Franken Introduces Legislation to End Drug Advertising Tax Breaks

March 4, 2016 – Yesterday Sen. Al Franken (D-Minn.) introduced legislation that would end the tax deduction that drug companies ... read more

CHC and CCC Launching Regulatory Compliance University for Agencies, Publishers

Aug. 19, 2015 – The Coalition for Healthcare Communication (CHC) is partnering with the Center for Communication Compliance (CCC) to ... read more

Author of “Pharmaphobia” Says Conflict-of-interest Regulations Are Slowing Medical Progress

June 8, 2015 – In his new book, “Pharmaphobia: How the Conflict of Interest Myth Undermines American Medical Innovation,” Tom ... read more

Previous Next

PhRMA: Engaging the Consumer Is Key to Healthcare Success

Aug. 12, 2013 — An increasing focus on the healthcare consumer’s needs and preferences may play a role in future industry product development priorities. According to a recent health survey commissioned the Pharmaceutical Research and Manufacturers of America (PhRMA), 86 percent of Americans believe that developing cures for more forms of cancer should be one of the top national health priorities, followed by effective treatment for heart disease (78 percent) and more intensive medical care for seniors (76 percent).

The PhRMA survey, “From Hope to Cures: PhRMA’s First Annual Health Survey,” was conducted by Hart Research Associates and “explores Americans’ attitudes on personal health and medical concerns.” This survey and the FDA’s ongoing initiatives to engage patients in dialogues about particular conditions and therapies – as well as clinical trials – demonstrate the growing role that consumers play in their own healthcare.

“Clearly, the PhRMA research demonstrates once again that patient communication and engagement is key to better health outcomes,” said Coalition for Healthcare Communication Executive Director John Kamp. “Indeed, public policy makers must begin to understand that medical communication by medicine companies plays a major part in the safe and effective use of medications.”

John J. Castellani, president and CEO of PhRMA, said in a statement that a patient-centric dialogue “is crucial to improving health outcomes,” and that the survey findings will help “inform efforts to address major health challenges such as chronic disease, improved prevention and wellness activities and enhanced patient adherence to prescribed therapies.”

Other consumer concerns listed in the survey findings are obesity, diet and weight management. For additional coverage of the survey, go to Medivo’s BTP Insights at: 

http://beyondthepill.medivo.com/2013/08/seeking-to-improve-outcomes-phrma-surveys-americans-to-find-out-about-leading-health-concerns/?utm_source=hs_email&utm_medium=email&utm_content=9950489&_hsenc=p2ANqtz–ddm8mrsUlFCgR_jo6roaueLdlegIjltGOKmM84cnP-Vt-l45g6tY66t9mbxYSfxYgOUJf18yJ5U5xg8uhSf2DqQ85Cg&_hsmi=9950489